BSECompany Update3h ago · 20 Aug 2026, 12:14 pm

Transcript of Conference Call for Investors and Analyst

Gem Aromatics Ltd · 544491

✦ AI SummaryResults

Gem Aromatics Ltd has released the transcript of its Q1 FY27 earnings conference call, highlighting Y-o-Y growth in revenue from operations, despite seasonal softness and impact from floods in Madagascar affecting raw material availability and pricing.

Analysis Scores

Earnings Impact6/10
Growth Catalyst4/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Gem Aromatics Ltd - 544491 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Attachments (1)

📄

4d6b3b7d-7209-406b-8231-449d8ff18a3e.pdf

pdf

Download →
View document text
Manufacturer & Exporters of Essential Oils & Aromatics Chemicals Registered Office: A/410-411, A-Wing, Kailash Ind. Complex, Powai Vikhroli link Rd, Vikhroli West, Mumbai-400079. Maharashtra, India, Tel No: +91-2225185231/25185931 CIN: L24246MH1997PLC111057 Date: August 20, 2026 To, To, Listing / Compliance Department Listing / Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G Dalal Street, Mumbai – 400 001 Bandra Kurla Complex Bandra (E), Mumbai – 400 051 BSE CODE: 544491 NSE SYMBOL: GEMAROMA Dear Sir/ Madam, Subject: Transcript of Conference Call for Investor and Analysts Pursuant to Regulation 30 and Para A of Part A of Schedule III and Regulation 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the transcript of the conference call for investors and analysts on the Q1 FY27 results held virtually by the Company on Friday, August 14, 2026. This intimation is also being uploaded on the Company’s website at www.gemaromatics.com. You are requested to take the same on your record. Thanking you, Yours faithfully, For Gem Aromatics Limited Akshita Deepak Gohil Company Secretary & Compliance Officer Encl: As Above Corporate Office: A/503, Kailash Ind. Complex, Powai Vikhroli link Rd, Vikhroli (W), Mumbai, Maharashrta, India, Pin - 400079. Facility 1: Plot No 2, Survey No.16/4/2, Near Alok Industries, Village Rakholi, Silvassa, Dadra & Nagar Haveli, Pin - 396230.Facility 2: Khasara No 8,9,10,126, Village Gathona, Ujhani Budaun Road, District: Budaun, UP, India, Pin # 243639. E-mail: secretarial@gemaromatics.in Web: www.gemaromatics.in “Gem Aromatics Limited Q1 FY27 Earnings Conference Call” August 14, 2026 MANAGEMENT: MR. YASH PAREKH – MANAGING DIRECTOR AND CHIEF EXECUTIVE OFFICER – GEM AROMATICS LIMITED MR. AADIT SHAH – CEO’S OFFICE – GEM AROMATICS LIMITED MODERATOR MR. AKHILESH GANDHI – STELLAR IR Page 1 of 16 Gem Aromatics Limited August 14, 2026 Moderator: Ladies and gentlemen, good day and welcome to the Q1 FY27 Conference Call hosted by Gem Aromatics Limited. As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during this conference call, please signal an operator by pressing star then zero on your touchtone phone. Please note that this conference is being recorded. I now hand the conference over to Mr. Akhilesh Gandhi from Stellar IR. Thank you and over to you, Mr. Gandhi. Akhilesh Gandhi: Thank you. Good evening, everyone. I, Akhilesh Gandhi, on behalf of Stellar Investor Relations, welcome you all to the Gem Aromatics Q1 FY27 Earnings Conference Call. We shall be sharing the key operating and financial highlights for the first quarter ended on June 30, 2026. Today, we have with us senior management team of Gem Aromatics Limited. Mr. Yash Parekh, he is the Managing Director and CEO. With him, we have Mr. Aadit Shah, he is from the CEO’s office. Before we begin, I would like to state that this call may contain some of the forward-looking statements, which are completely based upon the company’s beliefs, opinions, and expectations as of today. The statements made in today’s call are not a guarantee of future performance and also involve unforeseen risks and uncertainties. The company also undertakes no obligation to update any forward-looking statements to reflect development that occur after the statement is made. Document related to company’s financial performance, including press release and investor presentation, has already been uploaded on the stock exchange. With that, now I invite Mr. Yash to share his opening remarks on the company’s performance for the first quarter. Thank you and over to you. Yash Parekh: Good afternoon, everyone and a warm welcome to Gem Aromatics Earnings Conference Call for the first quarter of FY27. On behalf of the management team, I would like to thank all our investors, analysts, and stakeholders for joining us today and for your continued trust and support. Page 2 of 16 Gem Aromatics Limited August 14, 2026 Q1 FY27 witnessed Y-o-Y growth in revenue from operations, reflecting continued progress in the underlying business. At the same time, Q1 is seasonally a softer quarter and should be viewed in that context. During the quarter, our clove business was impacted by floods in Madagascar from where we source raw materials, which affected raw material availability and pricing as well as sales. A key focus during the quarter was the continued progress at our Dahej facility under Krystal Ingredients Private Limited. The facility is moving into the next phase of operations with the focus now on strengthening core customer engagement and expanding commercial opportunities across the newer product categories. Over the past years, we have made significant investments in expanding our manufacturing and product capabilities. A key part of our long- term strategy is to reduce our dependence on the traditional mint portfolio and build a more balanced mix across non-mint and higher value specialty products. Innovation and R&D remain important enablers of this strategy. With the continued focus on process, innovation, product customization, and development of higher value specialty molecules, our multipurpose manufacturing platform at Dahej also provides flexibility to respond to evolving customer requirements across different specialty chemistries, supporting our ability to build a broader specialty product portfolio. In addition to this, we have also had a strong R&D pipeline of new aroma chemicals products that are ready and many of them have been executed and are in different stages of execution. We are now continuing to strengthen our international presence. The company has approved the incorporation of a Brazil subsidiary, representing another step towards expanding our distribution reach in Latin America and creating a dedicated platform for our essential oils, aromatic chemicals, and specialty chemicals. Overall, we remain focused on disciplined execution, strengthening the capabilities built over the past few years. As we progress through the next phase of our expansion, our focus will remain on building a more diversified business, deepening the customer relationships, and creating a sustainable long-term value. With that, I will now hand over the Page 3 of 16 Gem Aromatics Limited August 14, 2026 call to Mr. Aadit Shah from the CEO’s office for a detailed discussion of the financial performance for the quarter. Thank you. Aadit Shah: Thank you. I will now take you through the financial performance for the first quarter of FY ‘27. Revenue from operations for the quarter stood at INR83 crores on a standalone basis compared to INR76 crores in Q1 FY ‘26. On a consolidated basis, the revenue stood at INR99 crores compared to INR88 crores in Q1 FY ‘26. The revenue performance was supported by improving business activity while Q1 is a seasonally softer quarter. Moving to profitability, on a standalone basis, gross profit stood at INR14.7 crores while at a gross margin of 17.7%, while EBITDA stood at INR8.5 crores with an EBITDA margin of 10.3%. On consolidated basis, gross profit stood at INR16.5 crores with a gross margin of 16.7%, while EBITDA stood at INR3.3 crores with an EBITDA margin of 3.3%. The gross margin and EBITDA margin performance during the quarter were impacted primarily by the product mix along with a higher raw material cost in the clove business following the supply disruption in Madagascar. In addition, the new plant carried a higher operating cost base while the newer product verticals are still progressing through their commercialization cycle and have not yet reached their full revenue potential. Moving to profitability, standalone PAT stood at INR7.3 crores during the quarter, while on a consolidated basis, the company reported [Showing first 8,000 characters — download PDF for full document]